Enterin
PrivateLast Round
Series A
Jul 17, 2017
Total Funding Raised
$12.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enterin is a biotechnology company that develops novel drugs designed to offer treatments that target the gut-brain axis and modify the course of neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enterin Comparables
Compare Enterin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vertero Therapeutics | 86% | |
| Stellate Therapeutics Inc. | 86% | |
| Kallyope | 77% | |
Enterin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 17, 2017 |
Key People
Founding team and executive leadership
Enterin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientia Ventures | Series A, VC Round |
| The Naissos Group | Series A, VC Round |
| Indie Asset Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 7, representing 50% of headcount.
- Nov 10, 2024
Monthly visitors grew 1000% MoM, from 70 to 770.
Enterin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enterin's valuation, stock price, and market status.